Cerebral white matter lesions, subjective cognitive failures, and objective neurocognitive functioning:A follow-up study in women after hypertensive disorders of pregnancy by Postma, Ineke R et al.
  
 University of Groningen
Cerebral white matter lesions, subjective cognitive failures, and objective neurocognitive
functioning
Postma, Ineke R; Bouma, Anke; de Groot, Jan Cees; Aukes, Annet M; Aarnoudse, Jan G;
Zeeman, Gerda G
Published in:
Journal of Clinical and Experimental Neuropsychology
DOI:
10.1080/13803395.2016.1143453
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2016
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Postma, I. R., Bouma, A., de Groot, J. C., Aukes, A. M., Aarnoudse, J. G., & Zeeman, G. G. (2016).
Cerebral white matter lesions, subjective cognitive failures, and objective neurocognitive functioning: A
follow-up study in women after hypertensive disorders of pregnancy. Journal of Clinical and Experimental
Neuropsychology, 38(5), 585-598. https://doi.org/10.1080/13803395.2016.1143453
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
Full Terms & Conditions of access and use can be found at
http://www.tandfonline.com/action/journalInformation?journalCode=ncen20
Download by: [145.97.168.221] Date: 29 March 2017, At: 03:19
Journal of Clinical and Experimental Neuropsychology
ISSN: 1380-3395 (Print) 1744-411X (Online) Journal homepage: http://www.tandfonline.com/loi/ncen20
Cerebral white matter lesions, subjective cognitive
failures, and objective neurocognitive functioning:
A follow-up study in women after hypertensive
disorders of pregnancy
Ineke R. Postma, Anke Bouma, Jan Cees de Groot, Annet M. Aukes, Jan G.
Aarnoudse & Gerda G. Zeeman
To cite this article: Ineke R. Postma, Anke Bouma, Jan Cees de Groot, Annet M. Aukes, Jan
G. Aarnoudse & Gerda G. Zeeman (2016) Cerebral white matter lesions, subjective cognitive
failures, and objective neurocognitive functioning: A follow-up study in women after hypertensive
disorders of pregnancy, Journal of Clinical and Experimental Neuropsychology, 38:5, 585-598, DOI:
10.1080/13803395.2016.1143453
To link to this article:  http://dx.doi.org/10.1080/13803395.2016.1143453
© 2016 The Author(s). Published by Informa
UK Limited, trading as Taylor & Francis
Group
Published online: 07 Mar 2016.
Submit your article to this journal Article views: 159
View related articles View Crossmark data
Citing articles: 2 View citing articles 
Cerebral white matter lesions, subjective cognitive failures, and objective
neurocognitive functioning: A follow-up study in women after
hypertensive disorders of pregnancy
Ineke R. Postmaa,b, Anke Boumac, Jan Cees de Grootb,d, Annet M. Aukese, Jan G. Aarnoudsea
and Gerda G. Zeemana,b
aDepartment of Obstetrics and Gynecology, University of Groningen, University Medical Center Groningen, Groningen, The
Netherlands; bSchool for Behavioural and Cognitive Neurosciences, GSMS BCN-Office, Groningen, The Netherlands; cDepartment
of Clinical and Developmental Neuropsychology, University of Groningen, Groningen, The Netherlands; dDepartment of
Radiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; eDepartment of Obstetrics
& Gynecology, VU University Medical Center, Amsterdam, The Netherlands
ABSTRACT
Objective: Hypertensive disorders of pregnancy, like preeclampsia, are a leading cause of
maternal and fetal morbidity/mortality worldwide. Preeclampsia can be complicated by the
occurrence of convulsions (eclampsia). Women who experienced (pre)eclampsia more
frequently report daily cognitive failures and showed increased emotional dysfunction
several years later, but are not impaired on objective neurocognitive testing. In addition,
women with preterm preeclampsia more often have cerebral white matter lesions (WML)
on follow-up. We aimed to determine whether WML presence is related to cognitive
dysfunction, anxiety, and depressive symptoms in (pre)eclamptic women. Method: Forty-
one eclamptic, 49 preeclamptic, and 47 control women who had a normotensive preg-
nancy completed the Cognitive Failures Questionnaire (CFQ), the Hospital Anxiety and
Depression Scale (HADS), and a broad neurocognitive test battery (visual perception and
speed of information processing, motor functions, working memory, long-term memory,
attention, and executive functioning). All underwent cerebral magnetic resonance imaging
(MRI), and WML presence was recorded. Median elapsed time since index pregnancy was 6
years. Average age was 40 years. Results: WML were more prevalent in women who had
experienced preterm (pre)eclampsia (<37 weeks; 40%) than in controls (21%, p = .03). In
(pre)eclamptic women, CFQ and HADS scores were higher than those in controls (44± 16.1
vs. 36± 11.0, p < .001, and 11± 6.3 vs. 8± 5.5, p < .001). There was no difference in objective
cognitive performance as measured by neurocognitive tests. Subjective and objective
cognitive functioning, anxiety, and depressive symptoms were not related to WML pre-
sence. Conclusion: Formerly (pre)eclamptic women report cognitive dysfunction, but do not
exhibit overt cognitive impairment when objectively tested on average 6 years following
their pregnancy. The presence of WML is not related to objective nor to subjective
cognitive impairment, anxiety, and depressive symptoms. Longitudinal studies are needed
to study whether the presence of WML is a risk factor for developing objective cognitive
impairment in the long term.
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Preeclampsia is a hypertensive multisystem disor-
der of pregnancy, which is a leading cause of
maternal and fetal/neonatal morbidity and mortal-
ity and affects 1–7% of all pregnancies. It is char-
acterized by new-onset hypertension (≥140 mmHg
systolic or ≥90 mmHg diastolic blood pressure)
combined with proteinuria after the 20th week of
pregnancy. In some cases, the maternal brain is
involved in the form of eclamptic seizures, cerebral
edema, and/or intracerebral hemorrhage. Recently,
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it has been shown that, several years later, formerly
preeclamptic and eclamptic women report cogni-
tive failures related to memory, attention, and
vision-related tasks of everyday life (Andersgaard
et al., 2009; Aukes, Wessel, Dubois, Aarnoudse, &
Zeeman, 2007; Postma, Bouma, Ankersmit, &
Zeeman, 2014; Postma et al., 2013; Wiegman
et al., 2012). In the literature, small studies evalu-
ating neurocognitive test performance in pree-
clamptic women within 1.5 years following the
index pregnancy have found impairment pertain-
ing to auditory–verbal memory (Brussé, Duvekot,
Jongerling, Steegers, & De Koning, 2008), speed of
information processing (Digit Symbol Coding of
Wechsler Adult Intelligence Scale–Third Edition,
Dutch Version, WAIS–III–NL), and divided atten-
tion (Paced Auditory Serial Addition Test; Baecke,
Spaanderman, & Van der Werf, 2009), but not on
other cognitive tests. In contrast, our recent study
evaluating cognitive functioning in a relatively
large group of women, on average 6 years follow-
ing a (pre)eclamptic pregnancy and using a broad
range of standardized neurocognitive tests, showed
that (pre)eclamptic women do not exhibit overt
cognitive impairment when tested objectively sev-
eral years following their pregnancy (Postma et al.,
2014). We argued that the reported cognitive fail-
ures may reflect actual neurocognitive dysfunction
in complex daily life situations, generally asso-
ciated with less structure and numerous distrac-
tions, which require more flexibility than a quiet,
structured test setting. Alternatively, subjective
cognitive failures may also be related to emotional
factors, as (pre)eclamptic women report more
anxiety and depressive symptoms (Baecke et al.,
2009; Postma et al., 2014) and more often seem
to develop posttraumatic stress disorder, which
may persist for several years (Delahaije, Dirksen,
Peeters, & Smits, 2013; Porcel et al., 2013). We
suggested that cognitive failures in formerly (pre)
eclamptic women may be interpreted as a measure
of executive control of behavior, in which people
who have symptoms of anxiety and depression
experience cognitive failures mainly in complex
and stressful daily life events.
Our group has previously studied the presence
of white matter lesions (WML) following (pre)
eclampsia and found that women who experienced
eclampsia or preterm (pre)eclampsia more often
have WML on long-term follow-up than do con-
trol women who had a normotensive pregnancy
(Aukes, De Groot, Aarnoudse, & Zeeman, 2009;
Aukes et al., 2012). The current study adds a new,
interesting question to our previously published
studies: Are these WML related to cognitive func-
tioning in women following a (pre)eclamptic preg-
nancy? We studied the effect of WML in a
relatively large group of formerly (pre)eclamptic
women and hypothesize that WML in women
who had (pre)eclampsia may have an effect on
standardized test measures of neurocognitive func-
tioning and may specifically be related to cognitive




Formerly eclamptic, preeclamptic, and control
women with normotensive pregnancies were
enrolled in this retrospective cohort study as part
of ongoing follow-up studies assessing long-term
cerebral consequences of preeclampsia and
eclampsia (Aukes et al., 2009; Aukes et al., 2012;
Postma et al., 2014; Wiegman et al., 2014). Women
with a diagnosis of eclampsia in their medical
history between 1988 and 2005 were identified
using the electronic admission, diagnosis, and
delivery databases of the University Medical
Center Groningen (UMCG), and additional for-
merly eclamptic women have been recruited to
participate in our follow-up studies through colla-
boration with two other tertiary referral centers:
VU University Medical Center Amsterdam and
Isala Clinics Zwolle (Aukes et al., 2009; Aukes
et al., 2012; Postma et al., 2014; Wiegman et al.,
2014). In total, 137 formerly eclamptic women
were identified from the UMCG database. Six of
these women were excluded, one because diagnosis
of eclampsia could not be confirmed, another
because of a history of a cerebrovascular accident,
and a third as a result of inability to understand
Dutch. In addition, three women had died in the
interim, two of whom were the result of cerebral
complications resulting from eclampsia and one as
a result of gynecologic cancer. Of the remaining
131 formerly eclamptic patients, 69 could be
reached and were willing to participate. Six of
them were subsequently excluded as a result of
contraindications for magnetic resonance imaging
(MRI) scanning, and 63 women remained. In the
original study (Aukes et al., 2009; Aukes et al.,
2012), each woman who had eclampsia was
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matched for age (within 1 year) and year of index
pregnancy (within 2 years) with a woman who had
a pregnancy complicated by preeclampsia, and also
with a parous control whose pregnancy had been
uncomplicated and normotensive. The group of
women who had preeclampsia and the group of
parous controls has expanded since the original
report (Aukes et al., 2009). Parous women in the
control group were recruited through the depart-
ment’s electronic delivery database as well as
among hospital employees and their family mem-
bers. Their records were evaluated to confirm that
the pregnancy was indeed uneventful and
normotensive.
Eclampsia and preeclampsia were defined accord-
ing to international criteria (Tranquilli et al., 2014).
Preeclampsia is defined as new-onset hypertension
(≥140 mmHg systolic or ≥90 mmHg diastolic) com-
bined with proteinuria after the 20th week of preg-
nancy, and eclampsia is defined as the occurrence of
tonic–clonic convulsions in a woman with pree-
clampsia. Preterm (pre)eclampsia was defined as
medically indicated delivery at <37 weeks of gesta-
tional age. Medical records were reviewed for accu-
racy of diagnosis and to extract clinical and
demographic characteristics. Participants were asked
to complete a brief questionnaire concerning basic
demographic characteristics and medical history.
Neurocognitive measurements were performed
between November 2008 and January 2012, whereas
neuroimaging studies were performed between July
2005 and January 2012.
Exclusion criteria were known epilepsy, a
known cerebrovascular accident, demyelinating
disorders, a history of intracranial infection or
any cranial neurosurgical procedure, the inabil-
ity to understand Dutch, MRI contraindications,
or pregnancy at the moment of testing. For all
women, elapsed time since the index pregnancy
had to be at least 12 months. During the study,
two eclamptic women were excluded as they
showed signs of malingering or underachieve-
ment, as evaluated by the Amsterdam Short-
Term Memory (ASTM) test, a symptom valida-
tion test presented as a short-term memory task
(Bouma, Mulder, Lindeboom, & Schmand,
2012). The ASTM test is a valid, standardized,
and widely used test to indicate malingering.
One control was excluded because she had pro-
fessional knowledge of the neurocognitive tasks.
Forty-one of 63 (65%) eclamptic women, 49/74
(66%) formerly preeclamptic women, and 47/75
(63%) controls who underwent MR imaging
participated in the neurocognitive test battery
and were included (Postma et al., 2014).
Education level was categorized according to the
system of Verhage as described in Bouma et al.
(2012): 1 being the lowest (less than primary school),
and 7 the highest (academic degree). None of the
women were in the low education group (Categories
1 and 2). Average was defined as Category 3–5 and
high as Category 6–7. The Dutch Adult Reading
Test (DART; Dutch version of the National Adult
Reading Test) was used to determine premorbid
intelligence (Bouma et al., 2012). The DART is a
valid, standardized test based on the assumptions
that reading ability (of irregular words) is relatively
independent of brain disorders, and it is a strong
predictor of intelligence in the normal population
(Bouma et al., 2012). No significant difference was
found between the groups. One participant had suf-
ficient knowledge of the Dutch language to fulfil the
tasks, but the DART could not be administered.
Another participant was unable to complete the
DART due to dyslexia.
This project was approved by the UMCG
Medical Ethical Committee, and all women signed
informed consent.
Questionnaires
Cognitive Failures Questionnaire (CFQ;
subJective cognitive functioning)
The Cognitive Failures Questionnaire (CFQ) evalu-
ates cognitive “failures,” or daily mistakes, com-
mitted in the completion of daily tasks (Broadbent,
Cooper, FitzGerald, & Parkes, 1982). It includes
questions like “Do you read something and find
you haven’t been thinking about it and must read
it again?” or “Do you fail to hear people speaking to
you when you are doing something else?”
Participants were asked to fill out the questionnaire
based on their experiences in the past 6 months. The
CFQ consists of 25 items, each scored on a 5-point
scale (0–4). The total scale ranges from 0–100, with
higher scores indicating more cognitive failures.
The Hospital Anxiety and Depression Scale
The Hospital Anxiety and Depression Scale
(HADS) is a self-assessment scale, developed to
detect states of depression, anxiety, and emotional
distress amongst patients with a variety of clinical
problems (Spinhoven et al., 1997). It consists of 14
items scored on a 4-point scale (0–3). Items were
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divided into two subscales: anxiety and depression,
both with a maximum score of 21, with higher
scores indicating more symptoms.
Neurocognitive tests
Participants completed a battery of 16 standar-
dized, reliable, and valid neurocognitive tests
divided into six cognitive domains (Bouma et al.,
2012; Lezak, Howieson, Bigler, & Loring, 2012).
Tests were administered in a fixed sequence
according to standardized instructions for each
measure by two advanced doctoral students who
were well trained by a neuropsychologist.
Measures were scored in a standardized fashion
outlined in the administration manual of each test.
Visual perception and speed of information
processing
Visual perception was measured using a Dutch
Incomplete Figures Test (GIT-2; Luteijn &
Barelds, 2004). This task measures perceptual clo-
sure (i.e., reconstructing an object from reduced
visual information): Participants had to recognize
20 incomplete pictures of familiar objects, per-
sons, or animals. The test was cut off when five
subsequent wrong answers were given. The num-
ber of correct responses was scored. Visual pro-
cessing speed was measured using the Digit
Symbol Coding (WAIS–III–NL; Wechsler, 2005),
Symbol Search (WAIS–III–NL; Wechsler, 2005),
and the Stroop Color–Word Test Part 1 (Word
Reading) and Part 2 (Color Naming; Hammes,
1971). During Digit Symbol Coding, the partici-
pant had to fill out as many symbols below num-
bers as possible in 120 s, using a code at the top of
the page (each number corresponded to a sym-
bol). The number of correct symbols was scored.
During Symbol Search, the participant had to
score whether or not one of two symbols was
repeated in a following sequence. The participants
were required to complete as many items as pos-
sible in 120 s, and the number of correct items
was calculated. The Stroop Color–Word Test con-
sists of 100 randomly distributed stimuli, pre-
sented in a 10 × 10 table. Part 1 requires the
participant to read words (red, green, blue, and
yellow) as fast as possible. Part 2 requires colors
to be named. Time to completion was recorded.
Motor functions
Visuomotor speed was measured using the
Grooved Pegboard Test, which consists of a board
with 25 holes, each hole containing a randomly
positioned slot. Pegs, with a key on one side, had
to be rotated and placed in the holes. The partici-
pant had to complete this task as fast as possible
for both the dominant and the nondominant hand
(Matthews & Kløve, 1964). The Trail Making Test
Part 5 (Motor Speed; Delis–Kaplan Executive
Function System, D-KEFS) requests participants to
follow a dotted line with a pencil as fast as possible
(Delis, Kaplan, & Kramer, 2007).
Working memory
Visuospatial working memory was assessed using
the Corsi Block-Tapping Test, consisting of nine
black cubes fastened to a black board in a random
order (Kessels, Van Zandvoort, Postma, Kapelle, &
De Haan, 2000). The digits 1–9 on the cubes are
only visible from the side of the examiner. The
participant was asked to repeat the sequences,
increasing in length, tapped by the examiner. The
task was performed forward and backwards and
ended after two wrong responses of the same
length. A total product score was derived from
the number of correct sequences and the block
span. The task is considered a nonverbal analogue
to Digit Span (WAIS–III–NL; Wechsler, 2005),
which was used to measure verbal working mem-
ory and consists of sequences of numbers, which
had to be repeated by the participant, first forward
and then backwards. The length of the sequences
was increasing from 2 to 9 digits. The task was
ended after two wrong responses of the same
length. The number of correct answers was scored.
For the Letter–Number Sequencing Test (WAIS–
III–NL; Wechsler, 2005), the participant had to
repeat sequences of letters and numbers, increasing
in length, simultaneously placing the numbers
first, in rising order, and then the letters, in alpha-
betical order. The task was ended after three wrong
responses of the same length, and the number of
correct answers was scored.
Long-term memory
Visuospatial long-term memory (LTM) was
assessed by the Dutch version of the Location
Learning Test (Administration Procedure II;
Kessels, Bucks, Willison, & Byrne, 2012). It con-
sists of 25 compartments on a sheet with 10 every-
day objects, located at different positions. It was
shown for 15 seconds, and afterwards the partici-
pant had to relocate cards with the 10 objects. The
test consisted of five consecutive trials, and a total
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score was derived. Verbal LTM was measured by
the Dutch version of the Rey Auditory Verbal
Learning Test in which participants had to recall
15 monosyllabic words (regardless of order) in five
successive trials (Bouma et al., 2012). The total
number of correctly recalled words in all trials
was scored.
Attention
Part 1 (Visual Scanning), Part 2 (Number
Sequencing), and Part 3 (Letter Sequencing) of the
Trail Making Test (D-KEFS) were used to measure
attention (Delis et al., 2007). These conditions
were designed to quantify key component skills
that are required for performing the Number–
Letter Switching condition described below.
Sheets with numbers and letters were presented,
and in Condition 1, the participant had to blot out
only the numbers “3” but not the other numbers,
and in Conditions 2 and 3, respectively, numbers
and letters had to be connected. Time to comple-
tion was recorded.
Executive functioning
Inhibitory control was assessed by Part 3 (Inhibitory
Control) of the Dutch Stroop Color–Word Test
(Hammes, 1971). Words were pictured in a different
color (e.g., the word “red” was pictured in green),
and the colors had to be named. Time to completion
was recorded. In addition, an interference score was
calculated by subtracting time to completion of part
3 and part 2. Part 4 of the Trail Making Test
(Number–Letter Switching) is similar to “Part B” of
the original Trail Making Test (Delis et al., 2007).
The participant had to switch between connecting
numbers and letters, and the task measures divided
attention and cognitive flexibility. Contrast scores
were calculated for Part 4 versus Part 1 (contrast
score 1), Part 4 versus Part 2 (contrast score 2),
Part 4 versus Part 3 (contrast score 3), and Part 4
versus Part 5 (contrast score 5). Fluency tasks con-
sisted of the Verbal Fluency Test (animals and pro-
fessions) and the Figure Fluency Test (Dutch version
of the Ruff Figure Fluency Test) for visuospatial flu-
ency (Mulder, Dekker, & Dekker, 2006). The Verbal
Fluency Test requires the participant to name as
many words in the categories “animals” and “profes-
sions” as possible within 1 minute. The number of
responses was scored. During the Figure Fluency
Test the participant had to draw as many unique
patterns as possible within 1 min (5 times), by con-
necting two or more dots with a straight line. The
number of unique patterns was scored. Planning was
measured by the Tower Test (D-KEFS; Delis et al.,
2007). The participant had to place two to five discs
from a start to an end position on a base with three
sticks, thus building a tower, using as few steps as
possible. There were nine items, increasing in diffi-
culty. A total achievement score was calculated.
Cerebral MR imaging protocol
Participants were invited to the Neuro-Imaging
Center of the School for Behavioural and
Cognitive Neurosciences in Groningen. The
detailed MRI protocol has been previously pub-
lished by our group (Aukes et al., 2009; Aukes
et al., 2012; Wiegman et al., 2014). All studies
were performed on a 3-T MRI system (Philips
Intera; Philips Medical Systems, Best, the
Netherlands). An experienced neuroradiologist
(J.C.G.), blinded for patient category, rated the
presence of WML and other structural brain
abnormalities. WML were considered to be pre-
sent if hyperintense on fluid-attenuated inversion
recovery (FLAIR) proton density-weighted and
T2-weighted images, and not as hypointense as
liquor on T1-weighted images. Correction for
inclusion of partial volume misclassification was
performed as described previously (Aukes et al.,
2012; Wiegman et al., 2014). The number of
small (less than 3 mm), medium (3–10 mm), or
large (greater than 10 mm) WML were counted.
Considering them spherical with a fixed diameter
per size category, a total approximated volume
for subcortical white matter lesions was deter-
mined. Due to the skewed, non-normal distribu-
tion of the WML volume, it was not possible to
use this quantification of the lesions for further
analysis.
Following MR imaging and a period of rest,
blood pressure was measured manually with an
aneroid sphygmomanometer. Women with a
blood pressure of ≥140/90 mmHg or current anti-
hypertensive medication use for their high blood
pressure were designated as currently hypertensive.
In cases of hypertension, the measurement was
repeated after 15 minutes.
Statistical analyses
Statistical analysis was performed using IBM
Statistical Package for the Social Sciences
Version 20 for Windows (SPSS, IBM, Chicago
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IL, USA). Raw test scores were used. All data
were checked for normality of distribution
using distribution curves, Shapiro–Wilks test,
and Levene’s test for homogeneity of variance.
Small deviations in test scores from a normal
distribution due to an outlier were accepted.
For measures (Trail Making Test) that were not
normally distributed, logarithmic transformation
was employed. There were no differences in out-
comes between these transformations and non-
parametric tests. Formerly preeclamptic and
eclamptic women were analyzed as one group
(n= 90), since no differences in subjective and
objective neurocognitive functioning as well as
WML presence were found between these two
groups in our previous study.
Patient characteristics were analyzed using t test
for normally distributed data, Mann–Whitney U
test for non-normally distributed data, and χ2 test
for categorical data. Single imputation was used to
replace two missing values in the questionnaire
(due to a missed question) and two missing values
(due to missing test forms) in the tests using esti-
mated means for the whole group. Mean and
median values were calculated before and after
imputation to ensure the absence of differences.
The presence of WML and other structural MRI
abnormalities between groups was compared using
one-sided Fisher’s Exact Test. WML volume was
analyzed using Mann–Whitney U test. A two-way
analysis of variance (ANOVA) was conducted to
explore the effect of group variable and WML on
CFQ and HADS scores. Multivariate analysis using
two-way multiple analysis of variance (MANOVA)
was performed to explore the impact of the group
variable and WML per cognitive domain. Analyses
were corrected for age, since the WML positive
group was found to be significantly older than
the WML negative group. Effect sizes (η2p) were
calculated in order to estimate the strength of
significant effects between groups (Fritz, Morris,
& Richler, 2012). An effect size of η2p = .01 was
defined as small, η2p =.06 as medium, and η
2
p =.14
as large (Fritz et al., 2012). Stroop interference
score and the Trail Making Test contrast scores
were not included in the MANOVA domains,
since these scores are not independent of the raw
scores. Instead, they were separately analyzed using
two-way ANOVA.
In order to detect a medium effect size of η2 = .06
on the two-way multivariate analysis of the test
domains for four groups [namely (pre)eclampsia
with WML, (pre)eclampsia without WML, controls
with WML, and controls without WML], with two
predictors (group, WML), with a power of .80 and
alpha of .05, inclusion of 34 women in each group
was needed (Faul, Erdfelder, Lang, & Buchner, 2007).
Results
Participants
Ninety formerly (pre)eclamptic women and 47
controls underwent both neuroimaging and neu-
rocognitive testing. As shown in Table 1 and as
expected, estimated gestational age at delivery and
birth weight were significantly lower in women
who had a (pre)eclamptic pregnancy. At the time
of imaging, (pre)eclamptic women had signifi-
cantly higher blood pressure and more often used
antihypertensive medication than controls.
WML and subjective cognitive functioning
Formerly (pre)eclamptic women tended to have sub-
cortical WML more often than controls (Table 2, p =
.06). Women with preterm (pre)eclampsia had sub-
cortical WML approximately twice as often as con-
trols (Table 2, p = .03). Although periventricular
WML were seen in four (pre)eclamptic women and
never in controls, this difference did not reach sta-
tistical significance (Table 2).
(Pre)eclamptic women reported more symptoms
than controls on the Cognitive Failure Questionnaire
(CFQ; Table 2) [two-way ANOVA, F(3, 133) = 7.75,
p < .01, η2 = .06]. The presence of WML was not
associated with more CFQ symptoms (Table 2) [two-
way ANOVA, F(3, 133) = 0.02, p = .89, η2 = .00].
Also, the relationship between WML and CFQ was
not different in (pre)eclamptic women compared to
controls, as indicated by the interaction factor [two-
way ANOVA, F(3, 133) = 0.22, p = .64, η2 = .00].
When the above-mentioned analyses were repeated
comparing only women with preterm (pre)eclampsia
to controls, the results were similar. Exclusion of
those women who had infarctions or periventricular
WML (n = 10) did not alter the results.
WML, anxiety, and depressive symptoms
(Pre)eclamptic women reported more symptoms
than controls on the HADS Total scale (Table 2)
[two-way ANOVA, F(3, 133) = 12.22, p < .01, η2 =
.09]. They also reported more symptoms on the
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HADS Anxiety subscale [two-way ANOVA, F(3,
133) = 11.02, p < .01, η2 = .08] and HADS
Depression subscale [two-way ANOVA, F(3, 133)
= 8.43, p < .01, η2 = .06]. The presence of WML
was not associated with HADS Total score
(Table 2) [two-way ANOVA, F(3, 133) = 0.40, p
= .53, η2 = .00]. Women with WML also did not
report more symptoms on the HADS Anxiety sub-
scale [two-way ANOVA, F(3, 133) = 0.14, p = .71,
η2 = .00] and HADS Depression subscale [two-way
ANOVA, F(3, 133) = 0.59, p = .44, η2 = .00]. The
effect of WML was not different between (pre)
eclamptic women and controls for the HADS
Total score, F(3, 133) = 3.22, p = .08, η2 = .02,
Anxiety, F(3, 133) = 2.26, p = .14, η2 = .02, and
Depression, F(3, 133) = 2.90, p = .09, η2 = .02, as
indicated by the interaction factor. When the
above-mentioned analyses were repeated compar-
ing women with preterm (pre)eclampsia to con-
trols, the results were similar; there was a
significant effect of preterm (pre)eclampsia versus
controls on CFQ/HADS score, but not of WML
presence. Exclusion of those women who had
infarctions or periventricular WML did not reveal
any different results.
WML and objective cognitive functioning
In Table 3, test results are shown comparing
both formerly (pre)eclamptic women and con-
trols with and without WML. Neither the pre-
sence of WML nor a history of (pre)eclampsia
Table 2. White matter lesions and the Cognitive Failures Questionnaire in (pre)eclampsia and controls.
Characteristic Pre(eclampsia) (n = 90) Controls (n = 47) p
Subcortical WML: n (%) 32 (36) 10 (21) .06
WML volume in WML positive women (ml): Mdn
(min–max)
0.11 (0.004–2.29) 0.11 (0.02–0.12) .51
Periventricular WML: n (%) 4 (4) 0 (0) .18
Infarcts: n (%) 6 (7) 1 (2) .25
CFQ Total score: M (SD) 44 (16.1) 36 (11.0) <.001
HADS Total score: M (SD) 11 (6.3) 8 (5.5) <.001
WML (n = 32) No WML (n = 58) WML (n = 10) No WML (n = 37)
CFQ Total score: M (SD) 44 (15.0) 45 (16.7) 33 (8.0) 37 (11.7)
HADS Total score: M (SD) 12 (6.5) 11 (6.2) 6 (5.1) 9 (5.5)
Preterm (pre)eclampsia (n = 62) Controls (n = 47)
Subcortical WML: n (%) 25 (40) 10 (21) .03
Note. WML = white matter lesions; CFQ = Cognitive Failures Questionnaire; HADS = Hospital Anxiety and Depression Scale.
Table 1. Overview of participant characteristics.
Characteristic (Pre)eclampsia (n = 90) Controls (n = 47) p
Age (years): M (SD) 39 (6.6) 40 (7.3) .38
Ethnicity (n Caucasian): n (%) 88 (98) 45 (98) .74
Elapsed time since index
pregnancy (years): Mdn
(min–max)
6 (1–20) 6 (1–27) .50
Birth weight of newborn (g):
Mdn (min–max)
1572 (300–4470) 3520 (2210–4620) <.01
EGA at delivery (weeks): Mdn
(min–max)






69 (77) 21 (45) <.01
Level of education .26
Average: n (%) 38 (42) 16 (35)








80 (60–110)a 75 (60–95)b <.01
Current hypertension: n (%) 30 (37)a 5 (11)b <.01
Migraine: n (%) 26 (29) 11 (23) .47
Smoking: n (%) 14 (16) 9 (19) .61
Note. EGA = estimated gestational age.
an = 81. bn = 45.
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was significantly associated with worse scores
on any of the neurocognitive test domains.
The effect of WML was not different between
(pre)eclamptic women and controls, as indi-
cated by the interaction factors. The Stroop
interference score was 29 (18.3) for (pre)
eclamptic women and 27 (11.3) for controls.
The results did not show significant main
effects of group [two-way ANOVA, F(3, 133)
= 0.009, p = .92] and WML [two-way
ANOVA, F(3, 133) = 0.03, p = .86], and the
interaction factor was also not significant [two-
way ANOVA, F(3, 133) = 0.07, p = .79]. The
contrast scores of the Trail Making Test
observed for (pre)eclamptic women and con-
trols, respectively, were as follows: contrast
score 1: 49 (21.3) and 45 (24.2); contrast score
2: 40 (20.7) and 36 (20.6); contrast score 3: 42
(20.1) and 39 (19.6); and contrast score 5: 44
(21.4) and 45 (22.8). There were no significant
effects of group, WML, and the interaction fac-
tor on any of the contrast scores (p > .05).
Results were not different when comparing
women with preterm (pre)eclampsia to controls,
except for a significant effect of preterm (pre)
eclampsia on the motor functions domain, F(3,
103) = 3.69, p = .02, which was the result of a
significant difference in the Trail Making Test
Part 5 (motor speed), F(3, 103) = 7.94, p < .01.
Exclusion of those women who had infarctions
or periventricular WML did not alter the
results.
Discussion
(Pre)eclamptic women reported more subjective
cognitive problems in daily life and reported
more anxiety and depressive symptoms at, on
average, 6 years follow-up than control women
who had a normotensive pregnancy. (Pre)eclamp-
tic women did not show cognitive impairment as
measured by extensive objective neurocognitive
testing. (Pre)eclamptic women more often have
WML on neuroimaging. However, in contrast to
our expectation, the presence of WML was not
related to subjective or objective measures of cog-
nitive functioning nor to anxiety and depressive
symptoms in (pre)eclamptic women or in women
who had a normotensive pregnancy.
Subcortical WML, which are thought to be
related to hypertension and cardiovascular risk
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(pre)eclampsia, and the prevalence of these WML
was especially high in women with preterm (pre)
eclampsia. This is in line with the finding that
women with preeclampsia, and especially those
women with preterm preeclampsia, have an
increased risk of hypertension and ischemic and
hemorrhagic stroke in later life (Bellamy, Casas,
Hingorani, & Williams, 2007).
WML were not related to objective neurocogni-
tive deficits. This study covers a broad range of
neurocognitive functions and incorporates sensi-
tive tests for measuring cognitive impairment.
Therefore, other factors need to be taken into
consideration to explain the lack of a relationship
between WML and objective neurocognitive
deficits.
First, young women with an average age of 40
years may not yet suffer overt sequelae related to
WML due to the compensational capacity of the
brain. Not the mere presence of WML, but more
so their severity may prove to be the main deter-
minant of impaired cognitive functioning. With
aging, the WML burden may increase and gray
matter volume decrease, and the aging brain may
have reduced ability to compensate for cognitive
dysfunction (Debette & Markus, 2010). Indeed
most associations between WML and cognitive
impairment are found in older people (De Groot
et al., 2000; Sachdev, Wen, Christensen, & Jorm,
2005). Although one could expect that the WML
volume would be larger in (pre)eclamptic women
than in controls, we did not find a significant
difference between these two groups. The two
groups are comparable with respect to WML
volume.
Second, WML location may play a role. Both
subcortical and periventricular WML are related
to hypertensive disease and coincide often.
However, mainly periventricular, more than sub-
cortical, WML seem to be associated with cogni-
tive impairment and dementia (Bolandzadeh,
Davis, Tam, Handy, & Liu-Ambrose, 2012; De
Groot et al., 2001; Gootjes et al., 2004; Kuller
et al., 2010; Taki et al., 2011). Periventricular
WML are thought to disrupt long connections
from subcortical structures to cortical areas,
whereas subcortical WML are thought to disrupt
intermediate cortico-cortical connections (Filley,
1998; Kim, MacFall, & Payne, 2008). In the pre-
sent study, most WML were located in the sub-
cortical regions, and only four women had
periventricular WML. This may, at least partially,
play a role in the lacking relationship of WML
presence with cognitive functioning.
We also hypothesized that WML would specifi-
cally be related to self-reported cognitive failures
(CFQ) in formerly (pre)eclamptic women.
However, we were not able to show a relationship
between WML presence and CFQ results. A pos-
sible explanation for this finding is that the CFQ
has a strong relationship with anxiety and depres-
sive symptoms in formerly (pre)eclamptic women
(Postma et al., 2014). (Pre)eclampsia is a serious
life event, in which women who are more sensitive
to stress may be more likely to develop anxiety and
depressive symptoms. In a previous study, depres-
sion and anxiety in early pregnancy seem to be
associated with increased risk of (pre)eclampsia,
and it is possible that symptoms of anxiety and
depression were already present prior to the index
pregnancy (Kurki, Hiilesmaa, Raitasalo, Mattila, &
Ylikorkala, 2000). The higher CFQ scores may
therefore have a more psychosocial explanation.
Alternatively, but related to the psychosocial expla-
nation, we hypothesize that higher CFQ scores
could be the result of dysfunction in executive
control, in which a higher burden of anxiety and
depressive symptoms leads women to experience
cognitive failures mainly in complex and stressful
daily life events. This interpretation is in agree-
ment with the view that the CFQ reflects a strong
interaction between negative emotions like stress
and anxiety and cognition. The CFQ measures
problems related to frequent lapses of memory—
for example, failures of attention in daily life, dis-
tractibility, forgetfulness, forgetting people’s names
(retrieval problems), and losing task goals during
task execution and was developed by Broadbent
et al. to measure cognitive failures, which make a
person vulnerable to showing bad effects of stress
(Broadbent et al., 1982). It may be viewed as a
reflection of a person’s experience of difficulties
with executive functioning in everyday life (e.g.,
“Do you have trouble making up your mind?”
and “Do you start doing one thing at home and
get distracted into doing something else (uninten-
tionally)?”). It may be difficult to capture these
difficulties using a neurocognitive test battery in a
laboratory environment, since executive function-
ing is especially appealed to in new, complex and
unknown situations, in which rapid and efficient
adjustment of behavior to the environment is
needed because routine solutions do not suffice.
Therefore, even when a person functions well in a
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structured test setting, there may still be problems
in novel and complex situations of everyday life in
which the individual needs to initiate, plan, orga-
nize, and monitor his own behavior (e.g., self-
initiation, self-organizing, self-monitoring, and
evaluating their purposeful behavior; Chaytor &
Schmitter-Edgecombe, 2003; Van der Linden,
Keijsers, Eling, & Van Schaijk, 2005). There is
substantial evidence that high levels of uncontrol-
lable or prolonged stress can have a detrimental
effect on prefrontal cognitive abilities, specifically
attention, working memory, and executive control
of behavior (Arnsten, 2009). We observed that
(pre)eclamptic women indeed showed enhanced
levels of stress like anxiety and depression.
Moreover, there is growing evidence that a com-
plex functional network of brain regions is
involved in regulating the interplay between cogni-
tion and emotion, involving the dorsolateral pre-
frontal cortex, the midcingulate cortex, and the
amygdala (Okon-Singer, Hendler, Pessoa, &
Shackman, 2015). However, we could not find
evidence that the subcortical white matter regions
were involved in tasks that rely on the executive
control of complex and stressful tasks. This could
explain why the CFQ is not related to WML
observed in (pre)eclamptic women. Further studies
using ecologically valid tests for executive func-
tioning are needed to test the hypothesis that the
CFQ is related to executive functioning in daily life
in this population of formerly (pre)eclamptic
women.
WML may be an early risk factor for later
development of objective cognitive impairment,
specifically in (pre)eclamptic women who main-
tained cognitive failures and symptoms of anxiety
and depression several years after delivery.
Advanced MRI techniques, such as diffusion-
weighted imaging (DWI), might be needed to
detect microstructural alterations in the white mat-
ter (Jokinen et al., 2013). Cerebral microbleeds are,
in older people, related to increased risk factors of
vascular disease (Van Norden et al., 2013).
As far as we know, this is the first study to report on
the presence of cerebral white matter lesions and its
relationship with subjective as well as objective cogni-
tive functioning and anxiety and depressive symptoms
in a relatively large group of formerly (pre)eclamptic
women. Moreover, it is one of the few studies in the
literature to report on the relationship of WML and
neurocognitive functioning in such a young cohort in
general. There are some limitations to this study,
which should be mentioned. The measurements in
this study have a cross-sectional design. Therefore,
the study does not provide imaging data of partici-
pants prior to or during their index pregnancy;
whether WML were present prior to the index preg-
nancy is therefore unknown. This design also limits
conclusions related to cause–effect relationships and
possible changes in cognitive functioning in daily life
due to pregnancy in and of itself. Second, although a
sample size calculation was performed, the sample size
of this study is considerably smaller than studies per-
formed in older people, and there were a low number
of controls with WML, which may have led to a Type
II error. We calculated that 34 women with WML
were needed in each group in order to obtain suffi-
cient power, and this criterion was not completely met
due to the low number of controls with WML. Third,
another limitation is the lack of quantitative analyses
for evaluating the effect of WML. Fourth, approxi-
mately 65% of the women who participated in our
previous studies (Aukes et al., 2009; Aukes et al., 2012)
could be contacted again and were willing to partici-
pate in this neurocognitive study, which may have
given rise to selection bias. It is possible that partici-
pating women experience more cognitive dysfunction
than nonparticipating women; however, most non-
participating women could not be contacted because
of change of address and/or phone number. Other
nonparticipating women mentioned the time and tra-
vel burden as the main reason not to participate,
although some declined because of fear of confronta-
tion with the traumatic experience of their compli-
cated pregnancy. Fifth, elapsed time since index
pregnancy shows a wide range, which reflects the
rare incidence of eclampsia. Sixth, the effect of subse-
quent pregnancies following the index pregnancy
cannot be excluded. Last, the formal diagnosis of
current hypertension in these women cannot be
made, since measurements were not performed on
multiple days.
Conclusion
In summary, cerebral subcortical WML are more
prevalent following preterm (pre)eclampsia.
Formerly (pre)eclamptic women report cognitive
dysfunction, but do not exhibit overt cognitive
impairment when objectively tested on average 6
years following their pregnancy. The presence of
WML is not related to objective nor to subjective
cognitive impairment, anxiety, and depressive
symptoms. Subjective cognitive failures seem to
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be related to symptoms of anxiety and depression
years after the (pre)eclamptic pregnancy, and we
hypothesize that they reflect executive function-
ing in complex and stressful daily life events. Our
results should not trivialize the perceived cogni-
tive dysfunction that these women report nor
does it exclude the possibility that (subgroups
of) these women develop cognitive impairment
in later life. This study has important clinical
implications for the follow-up of women who
experience subjective cognitive problems follow-
ing a (pre)eclamptic pregnancy, since these pro-
blems seem to be complex and related to stressful
activities of everyday life. Following a (pre)
eclamptic pregnancy, attention may be paid to
adequate psychosocial treatment and follow-up,
focusing on dysexecutive and emotional pro-
blems in daily life. Interventions, such as psy-
cho-education, providing women with advice on
maintaining an organized structure in daily life,
and cognitive behavioral therapy or Eye
Movement Desensitization and Reprocessing
(EMDR) may be beneficial (Ayers, McKenzie-
McHarg, & Eagle, 2007; Spikman, Boelen,
Lamberts, Brouwer, & Fasotti, 2010; Stramrood
et al., 2012). Future studies in women who
experienced eclampsia and preeclampsia should
focus on long-term follow-up (20–30 years) of
cerebral structural abnormalities and cognitive
functioning and adequate treatment options.
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